Institutional investors purchased a net $874.5 thousand shares of GHDX during the quarter ended September 2014 and now own 96.16% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BAKER BROS. ADVISORS LP Bought 205.8 Thousand shares of Genomic Health Inc
OXFORD ASSET MANAGEMENT LLP Bought 32.7 Thousand shares of Genomic Health Inc
ACADIAN ASSET MANAGEMENT LLC Bought 2.8 Thousand shares of Genomic Health Inc